ABSTRACT-Employing the isometric tension recording method, we studied the role of endothelium or endothelium-derived relaxing factor (EDRF) in the generation of rhythmic oscillations observed in contractile responses to various receptor agonists in isolated rabbit small mesenteric and epicardial coronary arteries. Norepinephrine (NE, 0.1-10 ttM) generated oscillatory contraction in endothelium-intact strips from the mesenteric arteries. Similarly, acetylcholine (ACh, 10 ttM), histamine (10 pM) and serotonin (10 ttM) generated oscillatory contraction in endothelium-intact strips from the coronary arteries. These agonistinduced oscillations in both arteries were consistently eliminated by either endothelial denudation or EDRF pathway inhibitors including 1Vc-nitro L-arginine (30 and 100 pM), oxyhemoglobin (3 and 10 pM) and methylene blue (3 and 10 pM). In contrast, EDRF releasers such as ACh or A23187 augmented the oscillations in the endothelium-intact strips. SNP (0.03 -30 pM) failed to generate oscillations in NE (10 pM)-preconstricted endothelium-denuded strips from the mesenteric arteries. In conclusion, these agonist-induced oscillations are probably mediated through EDRF. The inability of SNP to generate oscillations suggests the obligatory role of the endothelium in generation of the oscillations. The oscillatory release of EDRF by endothelial cells may be responsible for generation of the oscillations.
Rhythmic oscillations have been observed in contractile responses to a variety of agonists in a number of isolated vascular preparations (1-12). Correspondingly, rhythmic oscillatory changes in microvessel diameter, blood flow or blood pressure have also been documented in a number of in vivo vascular beds including bat wings (13, 14) , hamster skin fold (15) , cat mesenteric arterioles (16) , hamster cheek pouch (17) , rabbit skeletal muscle arterioles (18) , canine coronary artery (19) and human skin vessels (20, 21) . However, the frequency, amplitude or regularity of the oscillations observed both in vitro and in vivo is known to vary among the vessels.
The oscillatory contractile activity observed in resistance and coronary arteries have been suggested to be specifically related to hypertension (2, 3, 8, 9) and coronary vasospasm (22 -24) , respectively. However, the oscillatory contractions or blood flow oscillations have also been documented in a number of intact (normal strains) animals including healthy human volunteers (6, 7, 10-12, 20, 21) , suggesting that the oscillatory activity is a general characteristic of normal blood vessels rather than a specific characteristic of blood vessels in a certain pathological state (10, 15, 25) . The functional importance of the oscillatory contractile activity of blood vessels, often referred to as vasomotion, appears to be still a matter of discussion; however, the suggested physiological roles of vasomotion particularly in small arteries or arterioles are as follows: 1) regulation of vascular resistance in such a way that local tissue can receive blood flow at least intermittently, thereby preventing the tissue from becoming continuously hypoxic; 2) minimization of fluid filtration into the extravascular space by reducing hydrostatic pressure; and 3) enhancement of lymphatic drainage through the pumping action of closely adjacent arterioles
The cellular mechanisms behind generation of the oscillatory contractile responses have not been fully clarified. However, they may correlate with cytosolic Ca2+ oscillations, which have been documented in a wide variety of cells including vascular smooth muscle cells (5, 29, 30) . A variety of different mechanisms have been proposed to explain the cytosolic Ca 21 oscillations (5, 31, 32) . They may arise from a periodic release of Ca" from intracellular stores (5) or oscillatory changes in membrane potential, possibly due to an interplay between voltage-gated Ca 21 channels and K+ channels activities (5, 8, 30) .
The role of the endothelium in generation of the oscillatory contractile responses has recently attracted attention (6, 7, 10-12, 33, 34) . Jackson first demonstrated endothelium-dependence of the rhythmic oscillations observed in contractile responses to a variety of agonists in hamster aorta (6) . Recently, Jackson and co-workers further suggested that nitric oxide (NO) released from the endothelium may mediate the oscillatory responses to aadrenergic agonist by causing cytosolic Ca 21 oscillations as a result of cyclic guanosine 3',5'-cyclic monophosphate (cGMP) accumulation in smooth muscle cells (7) . These findings were subsequently confirmed by Gustafsson et al. in rat mesenteric artery (33) . However, Omote and Mizusawa failed to confirm the involvement of NO in a-adrenergic agonist-induced endothelium-dependent oscillations in rabbit ear artery (12) . In addition, the oscillatory contractile responses to various agonists including a-adrenergic agonists have been documented also in the absence of endothelium (1, 2, 7, 10, 12), suggesting an inherent ability of vascular smooth muscle cells to produce the oscillatory contraction. In support of this, cytosolic Ca 21 oscillations have been observed in single isolated vascular smooth muscle cells (29, 35) . Therefore, the role of the endothelium in the oscillatory contractile responses to agonists appears to be still a matter of discussion, and heterogeneity may exist in the mechanisms behind generation of the oscillatory contractile responses.
In this study, we investigated the role of the endothelium or NO in generation of the oscillatory contractile responses to various receptor agonists including norepinephrine (NE), acetylcholine (ACh), serotonin and histamine in rabbit small mesenteric or epicardial coronary arteries.
Tissue preparation and tension measurement
After receiving institutional approval, male albino rabbits (2.0-2.5 kg; Kajitani Experimental Animals, Fukuoka) were given sodium pentobarbital (40 mg/kg, i.v.) and exsanguinated. The mesentery in the jejunal region or the heart was immediately placed in a dissecting chamber filled with preoxygenated Krebs-bicarbonate solution, and the mesenteric or epicardial coronary artery (left anterior descending branch) was rapidly excised. The distal portion of the third-or fourth-order branches (0.15 -0.3 mm in outside diameter) were used for the experiments on mesenteric artery. The outside diameter of the coronary artery used in this experiment was = 0.7 -1.0 mm. Under a binocular microscope, after careful removal of the surrounding fat and connective tissues, the blood vessel was carefully cut open lengthwise. In some exepriments, the endothelium was then removed as described below. From this vascular sheet with or without endothelium, thin transverse strips (400 -600-pm-long and 80 -120-pmwide) were prepared. Both ends of the strip were then tied with two thin silk threads; and for the isometric tension measurement, the strip was fixed between one end of a chamber (0.9-m1 capacity) and a L-shaped glass rod connected to a strain gauge transducer (UL-2 type; Shinko Co., Tokyo) as previously reported (36, 37) . The chamber was mounted on a microscope stage, and the resting tension was adjusted to obtain the maximum contractile response to high K+. The solution was changed by perfusing it rapidly from one end while aspirating it simultaneously from the other end. All experiments were performed at 35 C .
In some experiments with both mesenteric and coronary arteries, the endothelium was removed before mounting the strip in the chamber (defined as "prior" endothelial denudation): the intimal surface was gently rubbed with a small pin using its round surface as previously described (36) . In some other experiments with the coronary arteries, in order to directly examine the effects of endothelial removal on the agonist-induced contractions, the endothelium was removed by gently rubbing its intimal surface with the same technique described above but in the chamber after recording the control vascular responses to agonists (defined as "direct" endothelial denudation). In order to make this "direct" mechanical removal of endothelium possible, the strips were mounted in the chamber horizontally with the intimal surface up. It was technically difficult to apply this technique to the strips from the mesenteric artery because of their thinness. The functional removal of the endothelium was confirmed by disappearance of endothelium-dependent relaxation by acetylcholine (10 pM) and A23187 (1 pM) in the mesenteric and coronary arteries, respectively, while the endothelium-intactness was verified by the almost complete (>_90070) relaxation by ACh (1 pM) or A23187
(1 pM) in the mesenteric and coronary arteries, respectively. The morphological removal of the endothelium with this technique has already been demonstrated in our previous immunohistochemical study (36) . All experiments were performed in the presence of guanethidine (3 pM) and tetrodotoxin (TTX) (0.3 eM) to minimize any possible influence of peripheral nerve activities.
Solutions and drugs
The ionic concentrations of the Krebs solution were as follows: 111.9 mM NaCI, 3.7 mM KCI, 1.2 mM MgC12, 2.6 mM CaC12, 25.5 mM NaHCO3, 1.2 mM KH3PO and 11.4 mM glucose. The high K+ solution was prepared by replacing NaCI with KCI, isoosmotically. The solutions were bubbled with 95% 02 / 5 % C02, and their pH was maintained at 7.3 -7.4. NE, ACh, guanethidine HCI, histamine, 5-hydroxytryptamine (5-HT, serotonin), N -nitro L-arginine (LNNA), methemoglobin (bovine), methylene blue (MB), sodium nitroprusside (SNP) and TTX were obtained from Sigma Chemical Co., St. Louis, MO, USA. Oxyhemoglobin (Hb02) was prepared by reducing commercial bovine Hb containing 75% methemoglobin as previously described by Martin et al. (38) . Briefly, after adding 10 times concentration of sodium dithionite to Hb (1 mM), dialysis by a 200-fold volume of distilled water was carried out at 4C. °The identification and final concentration of Hb02 were both determined spectrophotometrically.
Calculation and statistical analyses
All results are expressed as the mean±S.E.M. The n denotes the number of animals (=the number of preparations).
NE produced a transient phasic increase followed by a tonic increase in tension in both endothelium-intact and denuded strips. However, it was sometimes difficult to identify the NE-induced phasic contraction in the endothelium-denuded strips, probably because of enhanced tonic contraction. Therefore, only the concentrationresponse relationship for NE-induced tonic contraction was studied. In the experiments to examine the concentration-response relationship for NE contraction in the endothelium-intact and -denuded strips, the amplitude of 40 mM K+-induced phasic contraction in each condition was normalized as 100% to express the amplitude of the NE contraction, because the amplitude of high K+-induced contraction was previously suggested to be less sensitive to endothelial function in the isolated rabbit arteries (39) . In support of this, in this artery, the amplitude of 40 mM K+-induced phasic contraction was only slightly, although significantly, affected by a cocktail application of the EDRF inhibitors (P <0.05, by a paired Student's ttest); the amplitude of 40 mM K+-induced phasic contraction after exposure to a cocktail of LNNA (100 PM), HbO2 (10 pM) and MB (10 pM) was 1.11 ±0.04 (n=4) times the control. In contrast, the amplitude of 40 mM K+-induced tonic contraction was more strongly enhanced by these EDRF inhibitors (P < 0.05, by a paired Student's ttest): the amplitude of 40 mM K+-induced tonic contraction after exposure to a cocktail of LNNA (100 pM), Hb02 (10 pM) and MB (10 pM) was 2.18±0.28 (n=4) times the control. The statistical comparison of the concentration-response curve between endothelium-intact and -removed strips, however, was not made because it is conceivable that endothelial denudation significantly increases the amplitude of 40 mM K+-induced phasic contraction just like the EDRF inhibitors did.
The data points in the concentration-response relationships for NE and SNP were fitted according to the four parameter logistic model described by De Lean et al. (40) , and the EC50 or IC50 values (concentrations that produced 50010 of the maximal response) were derived from these fits.
The amplitude of the NE-induced oscillations was expressed relative to the amplitude of the 40 mM K+-induced phasic contraction (=1.0). The amplitude of the high K+-induced oscillations in mesenteric arteries was not assessed because the amplitude was often small and variable. Also in the coronary arteries study, only the fre- 
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inhibitors on the oscillatory contractions NE concentration-dependently (0.1-10 pM) generated the contraction both in the endothelium-intact and -denuded strips (Fig. 1) . The rhythmic oscillations were observed in the contractile responses to various concentrations (0.1-10 uM) of NE only in the endothelium-intact strips ( Fig. 1) , suggesting endothelium-dependence of the NE-induced oscillations. The appearance rate of the oscillations in the contractile responses to 10 pM NE in the endothelium-intact and -denuded strips were 91.5% (=76/83) and 0010 (=0/97), respectively. The mean frequency and amplitude of the NE-induced oscillations were 3.16-L0.06 cycles per minute (cpm) and 0.34-L0.02 times the amplitude of the 40 mM K+-induced phasic contraction, respectively (n = 76).
To characterize the endothelium-dependence of NE-induced oscillations, we next studied the effects of various inhibitors of the EDRF pathway including LNNA (30 and 100 tM), a selective inhibitor of EDRF (NO) synthesis; Hb02 (3 and 10 riM), known to bind and inactivate EDRF (38) ; MB (3 and 10 pM), an inhibitor of soluble guanylate cyclase activation (38) ; and a cocktail application of LNNA (100 pM), Hb02 (10 pM) and MB (10 pM) on the NE-induced oscillatory contraction in the endotheliumintact strips. The pretreatment with LNNA (30 and 100
[M) for 25 -45 min, Hb02 (3 and 10 ,uM) for 5 min, MB (3 and 10 pM) for 5 -25 min or a cocktail of LNNA (100 ttM), Hb02 (10 pM) and MB (10 pM) for 5-15 min completely abolished the NE-induced rhythmic oscillations with concomitant strong enhancement (P<0.05) of the NE contraction (Fig. 2) . Also in the coronary arteries, rhythmic oscillations vere observed in the contractile responses to various tgonists including ACh (10 pM), histamine (10 pM) and Fig. 2 . Effects of various inhibitors of the EDRF pathway and prior mechanical removal of the endothelium on the NE-induced oscillatory contractions in the mesenteric arteries. A: aI -a4, Examples of changes in NE-induced oscillatory contraction after exposure to LNNA (100 uM) for 25 min (al); HbO2 (10 rM) for 5 min (a2); MB (101M) for 5 min (a3); and a cocktail of LNNA (100 pM), Hb02 (10 pM) and MB (10,uM) for 15 min (a4). a5, An example of NE-induced contraction in the endothelium-denuded strip ("prior" endothelial denudation). Note the disappearance of rhythmic oscillations in the contractile responses to NE and enhancement of the contractile responses to NE after exposure to these EDRF pathway inhibitors. The EDRF inhibitors often caused small fluctuating contractions probably due to inhibition of basal release of EDRF; note the unstable baseline after application of the EDRF inhibitors (a2-a4). In the endothelium-denuded strip, even 10 PM ACh failed to relax the strip (a5). B: Enhancement of the NE contraction after application of various EDRF pathway inhibitors including LNNA (30 and 100 pM); Hb02 (3 and 10 pM); MB (3 and 10 pM); and a cocktail of LNNA (100 uM), Hb02 (10 pM) and MB (10 pM) (L+H+M). The cocktail of LNNA, Hb02 and MB more potently (P <0.05) enhanced the NE contraction than low or high concentration of each inhibitor alone. The data are expressed as means±S.E.M., n=6-27. *P<0.05 vs control in each group. 0 Control, 0 Low concentration, • High concentration. Fig. 3 . Effects of LNNA and mechanical removal of the endothelium on the rhythmic oscillatory contractile responses to various agonists in the coronary arteries. A: Examples of effects of exposure to LNNA (100 pM) for 25 min on the rhythmic oscillatory contractile responses to ACh (10 pM, al), histamine (His, 10 yM, a2) and serotonin (5-HT, 10 pM, a3). Note the disappearance of the oscillations in agonist-induced contractions as well as the enhancement of the agonists-induced contractions after exposure to LNNA. B: Examples of "direct" mechanical removal of the endothelium on the oscillatory contractile responses to ACh (10 teM, bl), histamine (His, 10 pM, b2) and serotonin (5-HT, 10 pM, b3). The intimal surface was rubbed in order to remove the endothelium in the experimental chamber after recording the control contractile response to each agonist. The recording was made 10 min after the rubbing. C: Effects of "prior" endothelial removal on the ACh-induced contraction. The endothelium was rubbed before mounting the strip in the chamber. A23187 (0.1 and 1 pM) failed to relax the strip. Similar observations were made in many other strips (n=14). D: Effects of LNNA and "direct" removal of the endothelium on the agonists-induced contractions. The amplitude of the maximal contraction evoked by each agonist before each intervention (control) was normalized as a relative tension of 100%. The data are expressed as means±S.E.M., n=4-9. *P<0.05 vs control. 0 Control, 0 Acetylcholine, 0 Histamine, 0 Serotonin. 5-HT (10,uM) only in the endothelium-intact strips (Fig.  3, A and B) , suggesting endothelium-dependence of the agonist-induced oscillations. The appearance rates of the oscillations in the contractile responses to ACh, histamine and 5-HT were 66.7% (12/18), 77.8% (14/18) and 66.7010 (12/18) of the tested strips, respectively. The frequency of the oscillations evoked by ACh, histamine and 5-HT were 6.34±0.58 (n=12), 5.76±0.63 (n=14) and 6.71 ±0.50 (n=12) cpm, respectively. No significant differences were observed among these frequencies, but these frequencies were significantly larger than the frequency of the NE-induced oscillations observed in mesenteric arteries. The rhythmic oscillations were never observed in the contractile responses to these agonists in the endotheliumdenuded ("prior" denudation) strips (n=14) (Fig. 3C) .
The exposure to LNNA (100 pM) for 25 min or the "di rect" removal of endothelium in the experimental bath almost completely abolished the rhythmic oscillations in contractile responses to ACh, histamine and 5-HT with concomitant dramatic enhancement of the contractile response to each agonist ( Fig. 3; A, B and D) . In two strips, EDRF-mediated vasodilation appeared so dominant that either ACh or 5-HT evoked significant contractions (without oscillations) only after application of LNNA. 
Regeneration or augmentation of the rhythmic oscillations by EDRF releasers
The agonists-induced rhythmic oscillations both in the mesenteric and coronary arteries were usually observed only in the early stage of the experiments for 2 -4 hr. After that, in most cases, they gradually decayed with the increase in the amplitude of the contractions (Fig. 4A) , and finally reached to another steady state where the oscillations had almost disappeared, but the endothelium-dependent relaxation were well-preserved (This state usually continues for ;::z:;3-6hr at 351C). However, application of ACh, an EDRF releaser, enhanced or regenerated the oscillations in such endothelium-intact strips where the NE-induced oscillations had been impaired or abolished with progress of the experiments (Fig. 4, A and B) . Rarely, the agonist-induced oscillations had already been attenuated or almost abolished from the very early stage of experiments in spite of the presence of endothelium-dependent relaxation. Again, application of ACh or A23187 augmented or regenerated the oscillations in such endothelium-intact strips where the agonist-induced rhythmic oscillations had been already impaired or abolished from the very early stage of the experiments (Fig. 4, C -E) . The ability of SNP to generate the oscillations in the endothelium-denuded strips from the mesenteric artery In order to know whether the endothelium is obligatory for the generation of the oscillations or not, we then examined the ability of SNP (0.03 -30 1M), a NO releasing compound (41) , to generate the oscillations in the absence of endothelium.
SNP produced concentration (1-30 iM)-dependent relaxation in the endothelium-denuded strips precontracted with NE (10 pM), where even 10 pM ACh failed to cause vasorelation (Fig. 5) . No rhythmic oscillations were evoked by application of various concentrations of ACh (0.03 -10 pM) or SNP (0.03 -30 pM) in the presence of NE (10 pM) (Fig. 5) . 
High-K+-induced oscillatory contraction
In several endothelium-intact strips from the mesenteric arteries, high K+ (40 mM) also produced rhythmic oscillations (Fig. 6) . The appearance rate of the oscillations in the contractile responses to 40 mM K+ in the endothelium-intact and -denuded strips were 14.5% (12/83) and 010 (0/97), respectively. The mean frequency of the high K+-induced oscillations was 2.96±0.19 cpm, which did not significantly different from that of NE-induced oscillations (3.16±0.06 cpm). The oscillations often became apparent a few minutes after application of high K+, and their amplitudes were often small and variable as compared to those of the NE-induced oscillations (Fig.  6 ).
The rhythmic oscillations in the contractile responses to various agonists in both mesenteric and coronary arteries were completely eliminated by the EDRF pathway inhibitors or endothelial denudation. In addition, the oscillations were augmented or regenerated by EDRF releasers in the strips where the oscillations had been impaired in spite of the presence of endothelium-dependent relaxations. These results suggest that the rhythmic oscillations in these rabbit arteries were probably mediated through EDRF (or NO). This proposal is in agreement with previous proposals regarding a-adrenergic agonist (phenylephrine [PE] or NE)-induced endothelium-dependent oscillations in aorta and rat mesenteric artery (6, 7, 33), but in disagreement with a recent proposal in rabbit ear artery that NO is not involved in the PE-induced endotheliumdependent oscillations. The inability of SNP to generate the oscillations in the NE-preconstricted endotheliumdenuded strips is inconsistent with the previous studies in aorta and mesenteric artery in which SNP or 8-bromo cyclic GMP induced the oscillations in PE-or NE-preconstricted endothelium-denuded preparations (7, 33) . Furthermore, although the PE-or NE-induced oscillations were completely eliminated after removal of the endothelium in the previous and present studies (7, 33) , removal of the endothelium did not significantly affect the NE-induced oscillations in rat aorta (10) or it did reduce but failed to completely eliminate the PE-induced oscillations in rabbit ear artery (12) . These considerable differences among the previous and present studies suggest heterogeneity in the mechanisms underlying the oscillatory contractile activity; they might be due to a species or regional difference or due to possible differences in in vitro experimental conditions.
The inability of SNP to generate the oscillations in our study suggests an obligatory role of the endothelium in generation of the oscillations observed in these rabbit arteries. It also suggests that the oscillations are not mediated only by a certain oscillatory intracellular signaling directly evoked by NO in vascular smooth muscle cells. Rather, the oscillations may reflect the oscillatory production and/or release of EDRF from the endothelial cells. The usual rundown of the agonist-induced oscillations may reflect reduced endothelial function or endothelial receptor desensitization in the course of the experiments.
Vascular endothelium is known to release various substances such as prostacyclin or EDRF in response to flowrelated forces such as pressure or shear stress (42).
Mechanically-gated ion channels (e.g., stretch-dependent cation channels) have been documented to exist in endothelial cells, and they have been proposed as possible candidates for permitting calcium to enter endothelial cells under physiological conditions (42) . These characteristics of endothelial cells indicate their high susceptibility to mechanical stimulation. Since in our experiments, the strips were horizontally mounted in the chamber under an isometric condition, the strips should not move in the horizontal direction, but might be able to slightly move in the perpendicular or vertical direction. If this is the case, application of vasoconstrictors could result in a mechanical stimulation (or stretch) of the endothelium. Alternatively, application of vasoconstrictors might result in electrical stimulation of the endothelium possibly via gap junctions between smooth muscle and endothelial cells as has recently been proposed (43, 44) . Therefore, one tempting explanation for generation of the oscillations could be that the endothelium generated the rhythmic oscillations by releasing EDRF in an oscillatory manner in response to the mechanical or electrical stimuli following application of vasoconstrictors.
In other words, successive transient vasorelaxation as a result of the EDRF release in response to potent vasoconstricting stimuli might lead to generation of the oscillations. The endothelium may be able to protectively release EDRF after somehow detecting that vascular smooth muscle has received potent vasoconstricting stimuli; the endothelium may appropriately possess a kind of negative feedback control system that protectively works against potent vasoconstricting stimuli in order to ensure the tissue blood flow. The oscillations therefore may reflect the interaction between endothelial and smooth muscle activities. The usual lack of oscillations in high K+-induced contraction could be explained by the known depressed function of depolarized endothelial cells because of a decrease in electrochemical gradient for Ca 21 influx into endothelial cells (42) .
Another possible explanation for the proposed oscillatory production or release of EDRF may be that the endothelial cells by nature (or inherently) produce and/or release EDRF in an oscillatory manner in response to stimuli. The oscillations may arise from a certain oscillatory intracellular signalling in the endothelial cells for synthesis and/or release of EDRF. This idea would be supported by previous observations that various agonists such as histamine, ACh or bradykinin evoke oscillations in intracellular Ca 21 level in endothelial cells (42, 45) .
The inability of SNP to generate the oscillations led us to propose that the oscillations arise from the oscillatory production and/or release of EDRF. We further proposed that the successive transient vasorelaxation as a result of protective release of EDRF by endothelial cells in response to potent vasoconstricting stimuli or the oscillatory release of EDRF resulting from the oscillatory intracellular signaling in endothelial cells may generate the oscillations. With these models, however, it may be difficult to straightforwardly explain the observed augmenting or regenerating effects of EDRF releasers such as ACh or A23187 on the oscillations. One possible explanation for this may be that the above-proposed ability of endothelial cells to release EDRF in response to potent vasoconstricting stimuli is readily desensitized or impaired with progress of the experiments, whereas the ability of endothelial cells to release EDRF in response to chemical stimulations such as agonists or calcium inonophore can be well-preserved. The stimulation of endothelial cells with ACh or A23187 therefore might be able to evoke the oscillations by causing cytosolic Ca2+ oscillations in the endothelial cells. Another possible explanation for this might be that the EDRF releasers can increase the susceptibility of the endothelial cells to the mechanical stimulations by activating (or sensitizing) some processes in endothelial cells that are essential for the endothelial cell to respond to the mechanical stimulations.
The inability of SNP to produce the oscillations may also be explained by critical involvement of some endothelial factors other than EDRF in generation of the oscillations. The intracellular signalling in vascular smooth muscle cells evoked by SNP with NE in the absence of endothelium may not be completely identical to that evoked by NE in the presence of endothelium. Some unknown processes that can be activated by NE in an endotheliumdependent manner in vascular smooth muscle cells may be critical for generation of the oscillations. Stimulation of vascular smooth muscle cells only with NO or SNP, therefore, might not be sufficient for generation of the oscillations. With this idea, oscillatory release of EDRF is not necessarily obligatory for generation of the oscillations. Moreover, with this idea, the ability of the EDRF releasers to regenerate the oscillations implies that the observed rundown of the oscillations is due to decreased basal release of EDRF with progress of the experiments. Since EDRF (NO) has been suggested to increase the cGMP level of vascular smooth muscle cells (38, 41) or to directly activate Ca 2+-dependent K+ channels of vascular smooth muscle cells (46) , adequately increased cGMP level or K+ channel activity in vascular smooth muscle cells due to basal or stimulated EDRF release might be prerequisite for generation of the oscillations. The difference in the ability of SNP to generate the oscillations in the absence of endothelium between the previous studies (7, 33) and our present one may be explained by this idea: some intracellular processes critical for generation of the oscillations might not be appropriately activated in the endothelium-denuded strips in our study. The oscillatory contractions may be able to emerge only when a number of intracellular processes essential for generation of the oscillations are appropriately activated. Alternatively, there may exist some kinds of oscillatory processes with different origins in vascular smooth muscle tissues that can induce the oscillatory contractile responses. Indeed, cytosolic Ca" oscillations have been documented in both vascular smooth muscle and endothelial cells (29, 30, 45) .
The appropriate level of vascular tone may be critical for generation of the oscillations, and the significant increases in vascular tone after treatment with the EDRF inhibitors might eliminate the oscillations. The EDRF releasers might regenerate the oscillations simply by decreasing the vascular tone. However, we failed to observe any oscillatory behavior in the endothelium-denuded strips precontracted with various concentrations of NE, i.e., in the presence of different levels of vascular tone (Fig. 1) . In addition, we could not observe any oscillatory activity in response to lower concentrations (0.06-0.1 uM) of NE in the strips treated with 100 pM LNNA, 10 pM Hb02 and 10 pM MB in our previous experiments in the same artery (36) . We therefore believe that the observed disappearance of the oscillations after treatments with the EDRF inhibitors is not due to the increases in vascular tone, but due to an inhibition of the EDRF pathway. Finally, SNP failed to generate the oscillations even after decreasing the vascular tone by 60% in the endothelium-denuded strips (Fig.5) , suggesting that the inability of SNP to generate the oscillations in the endothelium-denuded strips is not due to the increase in vascular tone after endothelial denudation.
Contractile responses to the various agonists were enhanced by both endothelial denudation and EDRF pathway inhibitors in either mesenteric or coronary arteries, suggesting that these agonists stimulate the release of EDRF either directly or mechanically as discussed above. To our knowledge, this study for the first time describes the direct effects of endothelium removal on the contractile responses to agonists in isolated coronary arteries. The effects of the EDRF inhibitors and mechanical removal of the endothelium were quite dramatic in the coronary arteries (-= 3 -18 times the control), suggesting that these agonists could trigger coronary vasoconstriction in situations where the endothelial function is impaired, e.g., as occurs in atherosclerotic patients. In fact, stimulation of the parasympathetic nervous system, release of histamine from mast cells or release of serotonin from platelets have been proposed as mechanisms responsible for the generation of coronary vasospasm (47, 48) .
Although the oscillatory contractile activity has been proposed to be specifically related to hypertension or coronary vasospasm (2, 3, 8, 9, 22-24), our present data suggest that the oscillatory vascular activity in both small resistance and epicardial coronary arteries represents the very intactness of the endothelium rather than impaired endothelial function, which is known to exist in patients with hypertension or coronary vasospasm (47) . In addition, the rabbit used in our study belongs to a normal strain. Therefore, the present study supports the view that the oscillatory behavior represents a general characteristic of normal blood vessels rather than a specific characteristic of blood vessels in hypertension or coronary vasospasm.
The oscillatory contractile activity in small arteries, often referred to as vasomotion, may contribute to regulation of vascular permeability by minimizing fluid filtration into the extravascular space through reduction of hydrostatic pressure (27) . Recent studies have demonstrated that inhibition of NO production by the endothelium results in an increase in vascular permeability, indicating that NO is an important regulator of vascular permeability (49, 50) . The inhibition of NO production may increase vascular permeability by causing endothelial cell contraction as a result of a decrease in cGMP level in endothelial cells (50) . However, if the vasomotion can really be effective in reducing fluid filtration into the extravascular space, the increase in vascular permeability after inhibition of NO production would also be explained by inhibition of the EDRF-mediated oscillatory vasomotion.
In conclusion, the rhythmic oscillations in the contractile responses to various agonists observed in both rabbit small mesenteric and coronary arteries are probably mediated through EDRF. The inability of SNP to generate the oscillations in the absence of endothelium suggests the obligatory role of endothelium in generation of the oscillations. The oscillatory production and/or release of EDRF in response to potent vasoconstricting stimuli may be responsible for generation of the endothelium-dependent oscillations.
